Hk Dachangyuan Pharmaceutical Group Limited Company Information

Current Status : Live


Hk Dachangyuan Pharmaceutical Group Limited's Hong Kong CR Number is 1910191. Incorporation Date is 21-MAY-2013. It's Winding up Mode is . Dissolution date is . Hk Dachangyuan Pharmaceutical Group Limited company is of Private company limited by shares Type.
Additional Remarks on the Hk Dachangyuan Pharmaceutical Group Limited company are .

Company Data

CRN1910191
Company NameHK DACHANGYUAN PHARMACEUTICAL GROUP LIMITED
Chinese Name香港大昌元藥業集團有限公司
Active StatusLive
Register of ChargesUnavailable
TypePrivate company limited by shares
See other companies with same Type - Private company limited by shares
Winding Up Mode
Date of Incorporation21-MAY-2013
See companies with same Incorporation Date - 21-MAY-2013
Date of Dissolution
Remarks
Important Note
Tagsdachangyuan   pharmaceutical   group   
Find Similar Companies by these tags.

Company Name History Information :

Effective DatePrevious Name
HK DACHANGYUAN PHARMACEUTICAL GROUP LIMITED21-MAY-2013

FAQs:

When was Hk Dachangyuan Pharmaceutical Group Limited incorporated?

Hk Dachangyuan Pharmaceutical Group Limited was incorporated on 21-MAY-2013 in Hongkong.

What is the type of Hk Dachangyuan Pharmaceutical Group Limited?

Hk Dachangyuan Pharmaceutical Group Limited is classified as Private company limited by shares.

What is the current status of Hk Dachangyuan Pharmaceutical Group Limited Company?

The status of Hk Dachangyuan Pharmaceutical Group Limited is Live.

What is the CR Number of Hk Dachangyuan Pharmaceutical Group Limited?

The CR Number of Hk Dachangyuan Pharmaceutical Group Limited is 1910191.

* We are trying our best to keep all the data correct and up-to-date. It should be noted that it is not the primary source of the information on the company Hk Dachangyuan Pharmaceutical Group Limited. The official registry should always be referred for latest information.

Last Updated on 14-07-2016.

Check other companies added on 14-07-2016

Check out Companies Incorporated on 21-MAY-2013: